These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1815 related items for PubMed ID: 22945622
1. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder. Schulz KP, Fan J, Bédard AC, Clerkin SM, Ivanov I, Tang CY, Halperin JM, Newcorn JH. Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622 [Abstract] [Full Text] [Related]
2. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK. Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731 [Abstract] [Full Text] [Related]
3. Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys. Cubillo A, Smith AB, Barrett N, Giampietro V, Brammer MJ, Simmons A, Rubia K. Cereb Cortex; 2014 Jan; 24(1):174-85. PubMed ID: 23048018 [Abstract] [Full Text] [Related]
4. Differential therapeutic effects of 12-week treatment of atomoxetine and methylphenidate on drug-naïve children with attention deficit/hyperactivity disorder: A counting Stroop functional MRI study. Chou TL, Chia S, Shang CY, Gau SS. Eur Neuropsychopharmacol; 2015 Dec; 25(12):2300-10. PubMed ID: 26409297 [Abstract] [Full Text] [Related]
5. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination. Smith A, Cubillo A, Barrett N, Giampietro V, Simmons A, Brammer M, Rubia K. Biol Psychiatry; 2013 Oct 15; 74(8):615-22. PubMed ID: 23731741 [Abstract] [Full Text] [Related]
6. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Bush G, Spencer TJ, Holmes J, Shin LM, Valera EM, Seidman LJ, Makris N, Surman C, Aleardi M, Mick E, Biederman J. Arch Gen Psychiatry; 2008 Jan 15; 65(1):102-14. PubMed ID: 18180434 [Abstract] [Full Text] [Related]
9. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K. JAMA Psychiatry; 2013 Feb 15; 70(2):185-98. PubMed ID: 23247506 [Abstract] [Full Text] [Related]
10. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory. Cubillo A, Smith AB, Barrett N, Giampietro V, Brammer M, Simmons A, Rubia K. Psychol Med; 2014 Feb 15; 44(3):633-46. PubMed ID: 23597077 [Abstract] [Full Text] [Related]
12. Differential effects of methylphenidate and atomoxetine on intrinsic brain activity in children with attention deficit hyperactivity disorder. Shang CY, Yan CG, Lin HY, Tseng WY, Castellanos FX, Gau SS. Psychol Med; 2016 Nov 15; 46(15):3173-3185. PubMed ID: 27574878 [Abstract] [Full Text] [Related]
13. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. Faraone SV, Glatt SJ. J Clin Psychiatry; 2010 Jun 15; 71(6):754-63. PubMed ID: 20051220 [Abstract] [Full Text] [Related]
14. Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine. Schulz KP, Bédard AV, Fan J, Hildebrandt TB, Stein MA, Ivanov I, Halperin JM, Newcorn JH. J Am Acad Child Adolesc Psychiatry; 2017 Jul 15; 56(7):602-609.e2. PubMed ID: 28647012 [Abstract] [Full Text] [Related]
15. Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex. Gilbert DL, Ridel KR, Sallee FR, Zhang J, Lipps TD, Wassermann EM. Neuropsychopharmacology; 2006 Feb 15; 31(2):442-9. PubMed ID: 16034446 [Abstract] [Full Text] [Related]